Deci­bel chief Holtz­man cham­pi­ons Fen­way as the new ‘hood in biotech; Aduro adds 2nd Keytru­da com­bo for can­cer

→ Deci­bel Ther­a­peu­tics CEO Steve Holtz­man isn’t just hop­ing to pi­o­neer new hear­ing drugs at his start­up. The Bio­gen vet is al­so cru­sad­ing to make Fen­way, a Boston neigh­bor­hood just across the Charles Riv­er from Cam­bridge, as the next big biotech hub in the city. To­day he and his fast-grow­ing staff of 50 moved in­to 32,000 square feet of fresh­ly ren­o­vat­ed lab space in Van Ness, lo­cat­ed at 1325 Boyl­ston Street. And he’s urg­ing oth­ers to fol­low his path to a neigh­bor­hood where rents are some­what more rea­son­able.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER